• Yer Ma@lemm.ee
    link
    fedilink
    arrow-up
    7
    ·
    1 year ago

    “Whether this translates to human biology, or is a potential risk to our health, is a topic of ongoing debate”

  • Ranvier
    link
    fedilink
    arrow-up
    7
    ·
    1 year ago

    Yeah I would not want to be the one to design that clinical trial. The slower moving a disease, the more difficult it is to test if something is having an effect on it. Nothing slower than aging.

  • XTL
    link
    fedilink
    arrow-up
    1
    ·
    1 year ago

    That sounds like a brand name. What’s the actual chemical?